首页 > 最新文献

Acta medica Okayama最新文献

英文 中文
Is Proximal Triangular Fixation Better than the Conventional Method in Adult Spinal Deformity Surgery? 在成人脊柱畸形手术中,近端三角固定法是否优于传统方法?
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-01 DOI: 10.18926/AMO/66669
Masato Tanaka, Umesh Meena, Takuya Taoka, Yoshihiro Fujiwara, Daiichiro Yokomizo, Santosh Kumar Bashyal, Naveen Sake, Shinya Arataki

In adult spinal deformity (ASD) surgery, one of the key factors working to prevent proximal junctional kyphosis is the proximal anchor. The aim of this study was to compare clinical and radiographic outcomes of triangular fixation with conventional fixation as proximal anchoring techniques in ASD surgery. We retrospectively evaluated 54 patients who underwent corrective spinal fusion for ASD. Fourteen patients underwent proximal triangular fixation (Group T; average 74.6 years), and 40 patients underwent the conventional method (Group C; average 70.5 years). Clinical and radiographic outcomes were assessed using visual analogue scale (VAS) values for back pain and the Oswestry disability index (ODI). Radiographic evaluation was also collected preoperatively and postoperatively. Surgical times and intraoperative blood loss of the two groups were not significantly different (493 vs 490 min, 1,260 vs 1,173 mL). Clinical outcomes such as VAS and ODI were comparable in the two groups. Proximal junctional kyphosis in group T was slightly lower than that of group C (28.5% vs 47.5%, p=0.491). However, based on radiology, proximal screw pullout occurred significantly less frequently in the triangular fixation group than the conventional group (0.0% vs 22.5%, p=0.049). Clinical outcomes in the two groups were not significantly different.

在成人脊柱畸形(ASD)手术中,近端固定是防止近端交界性脊柱后凸的关键因素之一。本研究旨在比较三角固定与传统固定作为 ASD 手术近端锚定技术的临床和影像学效果。我们回顾性评估了 54 例因 ASD 而接受脊柱融合术矫正的患者。14名患者接受了近端三角固定(T组;平均74.6岁),40名患者接受了传统方法(C组;平均70.5岁)。采用背痛视觉模拟量表(VAS)值和奥斯韦特里残疾指数(ODI)评估临床和放射学结果。此外,还收集了术前和术后的放射学评估结果。两组的手术时间和术中失血量无明显差异(493 分钟对 490 分钟,1260 毫升对 1173 毫升)。两组患者的临床疗效(如 VAS 和 ODI)相当。T 组的近端交界性后凸略低于 C 组(28.5% vs 47.5%,P=0.491)。然而,根据放射学结果,三角固定组发生近端螺钉拔出的频率明显低于传统固定组(0.0% vs 22.5%,P=0.049)。两组的临床结果无明显差异。
{"title":"Is Proximal Triangular Fixation Better than the Conventional Method in Adult Spinal Deformity Surgery?","authors":"Masato Tanaka, Umesh Meena, Takuya Taoka, Yoshihiro Fujiwara, Daiichiro Yokomizo, Santosh Kumar Bashyal, Naveen Sake, Shinya Arataki","doi":"10.18926/AMO/66669","DOIUrl":"10.18926/AMO/66669","url":null,"abstract":"<p><p>In adult spinal deformity (ASD) surgery, one of the key factors working to prevent proximal junctional kyphosis is the proximal anchor. The aim of this study was to compare clinical and radiographic outcomes of triangular fixation with conventional fixation as proximal anchoring techniques in ASD surgery. We retrospectively evaluated 54 patients who underwent corrective spinal fusion for ASD. Fourteen patients underwent proximal triangular fixation (Group T; average 74.6 years), and 40 patients underwent the conventional method (Group C; average 70.5 years). Clinical and radiographic outcomes were assessed using visual analogue scale (VAS) values for back pain and the Oswestry disability index (ODI). Radiographic evaluation was also collected preoperatively and postoperatively. Surgical times and intraoperative blood loss of the two groups were not significantly different (493 vs 490 min, 1,260 vs 1,173 mL). Clinical outcomes such as VAS and ODI were comparable in the two groups. Proximal junctional kyphosis in group T was slightly lower than that of group C (28.5% vs 47.5%, p=0.491). However, based on radiology, proximal screw pullout occurred significantly less frequently in the triangular fixation group than the conventional group (0.0% vs 22.5%, p=0.049). Clinical outcomes in the two groups were not significantly different.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"78 1","pages":"37-46"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Continuous Low-Dose Lenvatinib for the Treating of the Patients with Unresectable Thyroid Carcinoma. 持续低剂量伦伐替尼治疗无法切除的甲状腺癌患者的意义
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-01 DOI: 10.18926/AMO/66672
Daizo Murakami, Kohei Nishimoto, Soshi Takao, Satoru Miyamaru, Tomoka Kadowaki, Haruki Saito, Hiroki Takeda, Momoko Ise, Koichi Suyama, Yorihisa Orita

The tyrosine kinase inhibitor lenvatinib has been confirmed as an effective treatment option for patients with unresectable thyroid carcinoma. We conducted a retrospective analysis of the significance of the effect of continued lenvatinib treatment for the longest duration possible at a reasonable daily dose and with a minimum discontinuation period in 42 patients with unresectable thyroid carcinoma treated with lenvatinib between 2015 and 2020. A Cox proportional hazard model-based analysis revealed that the overall survival of the patients treated with a <8 mg/day mean dose of lenvatinib was significantly better than that of the patients treated with 8-24 mg/day (hazard ratio [HR] 0.38 for 1.14-4.54 mg/day, and HR 0.01 for 4.56-7.97 mg/day) adjusted for various factors (e.g., sex, age, drug interruption period). The cumulative dose of lenvatinib administered tended to be higher in the patients treated with low doses (< 8 mg/day) than in the patients treated with relatively high doses (8-24 mg/day). Considering its adverse events, the continuation of lenvatinib treatment with an adequate daily dose and drug interruption may help prolong the survival of patients with unresectable thyroid carcinoma.

酪氨酸激酶抑制剂来伐替尼已被证实是不可切除甲状腺癌患者的有效治疗选择。我们对2015年至2020年间接受来伐替尼治疗的42例无法切除的甲状腺癌患者进行了一项回顾性分析,以合理的每日剂量和最短的停药时间,尽可能延长来伐替尼的持续治疗时间。基于Cox比例危险模型的分析表明,接受来伐替尼治疗的患者的总生存期比接受来伐替尼治疗的患者的总生存期短。
{"title":"Significance of Continuous Low-Dose Lenvatinib for the Treating of the Patients with Unresectable Thyroid Carcinoma.","authors":"Daizo Murakami, Kohei Nishimoto, Soshi Takao, Satoru Miyamaru, Tomoka Kadowaki, Haruki Saito, Hiroki Takeda, Momoko Ise, Koichi Suyama, Yorihisa Orita","doi":"10.18926/AMO/66672","DOIUrl":"10.18926/AMO/66672","url":null,"abstract":"<p><p>The tyrosine kinase inhibitor lenvatinib has been confirmed as an effective treatment option for patients with unresectable thyroid carcinoma. We conducted a retrospective analysis of the significance of the effect of continued lenvatinib treatment for the longest duration possible at a reasonable daily dose and with a minimum discontinuation period in 42 patients with unresectable thyroid carcinoma treated with lenvatinib between 2015 and 2020. A Cox proportional hazard model-based analysis revealed that the overall survival of the patients treated with a <8 mg/day mean dose of lenvatinib was significantly better than that of the patients treated with 8-24 mg/day (hazard ratio [HR] 0.38 for 1.14-4.54 mg/day, and HR 0.01 for 4.56-7.97 mg/day) adjusted for various factors (e.g., sex, age, drug interruption period). The cumulative dose of lenvatinib administered tended to be higher in the patients treated with low doses (< 8 mg/day) than in the patients treated with relatively high doses (8-24 mg/day). Considering its adverse events, the continuation of lenvatinib treatment with an adequate daily dose and drug interruption may help prolong the survival of patients with unresectable thyroid carcinoma.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"78 1","pages":"63-70"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139988996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Macrophages in Liver Fibrosis. 巨噬细胞在肝纤维化中的作用
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-01 DOI: 10.18926/AMO/66664
Cuiming Sun, Akihiro Matsukawa

Liver fibrosis, which ultimately leads to liver cirrhosis and hepatocellular carcinoma, is a major health burden worldwide. The progression of liver fibrosis is the result of the wound-healing response of liver to repeated injury. Hepatic macrophages are cells with high heterogeneity and plasticity and include tissue-resident macrophages termed Kupffer cells, and recruited macrophages derived from circulating monocytes, spleen and peritoneal cavity. Studies have shown that hepatic macrophages play roles in the initiation and progression of liver fibrosis by releasing inflammatory cytokines/chemokines and pro-fibrogenic factors. Furthermore, the development of liver fibrosis has been shown to be reversible. Hepatic macrophages have been shown to alternately regulate both the regression and turnover of liver fibrosis by changing their phenotypes during the dynamic progression of liver fibrosis. In this review, we summarize the role of hepatic macrophages in the progression and regression of liver fibrosis.

肝纤维化最终会导致肝硬化和肝细胞癌,是全球主要的健康负担。肝纤维化的进展是肝脏对反复损伤的伤口愈合反应的结果。肝巨噬细胞是一种具有高度异质性和可塑性的细胞,包括被称为 Kupffer 细胞的组织驻留巨噬细胞,以及来自循环单核细胞、脾脏和腹腔的招募巨噬细胞。研究表明,肝巨噬细胞通过释放炎性细胞因子/凝血因子和促纤维化因子,在肝纤维化的发生和发展过程中发挥作用。此外,肝纤维化的发展已被证明是可逆的。肝巨噬细胞在肝纤维化的动态发展过程中通过改变其表型,交替调节肝纤维化的消退和转化。在这篇综述中,我们总结了肝巨噬细胞在肝纤维化进展和消退中的作用。
{"title":"Role of Macrophages in Liver Fibrosis.","authors":"Cuiming Sun, Akihiro Matsukawa","doi":"10.18926/AMO/66664","DOIUrl":"10.18926/AMO/66664","url":null,"abstract":"<p><p>Liver fibrosis, which ultimately leads to liver cirrhosis and hepatocellular carcinoma, is a major health burden worldwide. The progression of liver fibrosis is the result of the wound-healing response of liver to repeated injury. Hepatic macrophages are cells with high heterogeneity and plasticity and include tissue-resident macrophages termed Kupffer cells, and recruited macrophages derived from circulating monocytes, spleen and peritoneal cavity. Studies have shown that hepatic macrophages play roles in the initiation and progression of liver fibrosis by releasing inflammatory cytokines/chemokines and pro-fibrogenic factors. Furthermore, the development of liver fibrosis has been shown to be reversible. Hepatic macrophages have been shown to alternately regulate both the regression and turnover of liver fibrosis by changing their phenotypes during the dynamic progression of liver fibrosis. In this review, we summarize the role of hepatic macrophages in the progression and regression of liver fibrosis.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"78 1","pages":"1-8"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139988995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ectopic Breast Cancer Arising within an Axillary Lymph Node. 发生在腋窝淋巴结内的异位乳腺癌
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-01 DOI: 10.18926/AMO/66676
Kei Toshima, Tadahiko Shien, Midori Filiz Nishimura, Yoko Suzuki, Shogo Nakamoto, Maya Uno, Ryo Yoshioka, Takahiro Tsukioki, Yuko Takahashi, Takayuki Iwamoto, Tsuguo Iwatani, Hiroyuki Yanai

We report our experience with the diagnosis and treatment of an ectopic breast cancer arising within an axillary lymph node. The patient was a 65-year-old woman diagnosed breast cancer and axillary lymph node metastasis. We performed a partial mastectomy and axillary lymph node dissection. Postoperative pathology revealed no malignant lesions in the breast; however, a nodule in one of axillary lymph nodes had mixed benign and malignant components, leading to a diagnosis of invasive ductal carcinoma derived from ectopic mammary tissue. This case represents a very rare form of breast cancer, and the malignancy was difficult to distinguish from metastasis.

我们报告了腋窝淋巴结内异位乳腺癌的诊断和治疗经验。患者是一名 65 岁的女性,确诊为乳腺癌和腋窝淋巴结转移。我们为她实施了乳房部分切除术和腋窝淋巴结清扫术。术后病理结果显示,乳房无恶性病变;但其中一个腋窝淋巴结内的结节有良性和恶性混合成分,因此诊断为异位乳腺组织浸润性导管癌。该病例是一种非常罕见的乳腺癌,其恶性程度很难与转移区分开来。
{"title":"Ectopic Breast Cancer Arising within an Axillary Lymph Node.","authors":"Kei Toshima, Tadahiko Shien, Midori Filiz Nishimura, Yoko Suzuki, Shogo Nakamoto, Maya Uno, Ryo Yoshioka, Takahiro Tsukioki, Yuko Takahashi, Takayuki Iwamoto, Tsuguo Iwatani, Hiroyuki Yanai","doi":"10.18926/AMO/66676","DOIUrl":"10.18926/AMO/66676","url":null,"abstract":"<p><p>We report our experience with the diagnosis and treatment of an ectopic breast cancer arising within an axillary lymph node. The patient was a 65-year-old woman diagnosed breast cancer and axillary lymph node metastasis. We performed a partial mastectomy and axillary lymph node dissection. Postoperative pathology revealed no malignant lesions in the breast; however, a nodule in one of axillary lymph nodes had mixed benign and malignant components, leading to a diagnosis of invasive ductal carcinoma derived from ectopic mammary tissue. This case represents a very rare form of breast cancer, and the malignancy was difficult to distinguish from metastasis.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"78 1","pages":"89-93"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High Fracture Rate of AVANTA Silicone Implant Following Arthroplasty of the Thumb MCP Joint of Rheumatoid Arthritis Patients with Boutonniere Deformities. 类风湿性关节炎患者拇指 MCP 关节成形术后,AVANTA 硅胶假体的骨折率较高。
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2024-02-01 DOI: 10.18926/AMO/66673
Daisuke Kaneda, Keiichiro Nishida, Yoshihisa Nasu, Ryuichi Nakahara, Ryozo Harada, Yoshifumi Hotta, Shuichi Naniwa, Toshifumi Ozaki

We retrospectively investigated the mid-term outcomes of arthroplasty using the AVANTA silicone implant for thumb metacarpophalangeal (MCP) joints with boutonniere deformity in patients with rheumatoid arthritis (RA). This study involved 36 thumbs of 33 RA patients with a mean follow-up period of 5.1 years (range, 2.0-13.3). Postoperatively, the mean extension was significantly increased and the mean flexion was significantly decreased (p<0.001, p<0.001, respectively), resulting in the mean arc of range of motion (ROM) shifting in the direction of extension after surgery. Implant fracture was observed in 10 thumbs (28%), and 4 of these (11%) underwent revision surgery. The survivorship with implant fracture and revision surgery as endpoints were 73.4% and 91.8% at 5 years, respectively. The preoperative arc of ROM and the postoperative flexion range of the implant-fracture group were significantly greater than those in the no-implant-fracture group (p=0.039, 0.034, respectively). These results suggest the importance of patient education and careful rehabilitation to prevent excessive flexion. Overall, the AVANTA silicone implant showed a relatively high rate of implant fracture at our institute.

我们回顾性研究了使用 AVANTA 硅胶假体为类风湿性关节炎(RA)患者拇指掌指关节(MCP)进行关节置换术的中期疗效。这项研究涉及 33 名类风湿关节炎患者的 36 根拇指,平均随访时间为 5.1 年(2.0-13.3 年)。术后,平均伸展度明显增加,平均屈曲度明显减少(p
{"title":"High Fracture Rate of AVANTA Silicone Implant Following Arthroplasty of the Thumb MCP Joint of Rheumatoid Arthritis Patients with Boutonniere Deformities.","authors":"Daisuke Kaneda, Keiichiro Nishida, Yoshihisa Nasu, Ryuichi Nakahara, Ryozo Harada, Yoshifumi Hotta, Shuichi Naniwa, Toshifumi Ozaki","doi":"10.18926/AMO/66673","DOIUrl":"10.18926/AMO/66673","url":null,"abstract":"<p><p>We retrospectively investigated the mid-term outcomes of arthroplasty using the AVANTA silicone implant for thumb metacarpophalangeal (MCP) joints with boutonniere deformity in patients with rheumatoid arthritis (RA). This study involved 36 thumbs of 33 RA patients with a mean follow-up period of 5.1 years (range, 2.0-13.3). Postoperatively, the mean extension was significantly increased and the mean flexion was significantly decreased (p<0.001, p<0.001, respectively), resulting in the mean arc of range of motion (ROM) shifting in the direction of extension after surgery. Implant fracture was observed in 10 thumbs (28%), and 4 of these (11%) underwent revision surgery. The survivorship with implant fracture and revision surgery as endpoints were 73.4% and 91.8% at 5 years, respectively. The preoperative arc of ROM and the postoperative flexion range of the implant-fracture group were significantly greater than those in the no-implant-fracture group (p=0.039, 0.034, respectively). These results suggest the importance of patient education and careful rehabilitation to prevent excessive flexion. Overall, the AVANTA silicone implant showed a relatively high rate of implant fracture at our institute.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"78 1","pages":"71-78"},"PeriodicalIF":0.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139989051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of a Series of Surveys on Adverse Reactions to the COVID-19 mRNA-1273 Vaccine at Okayama University. 冈山大学 COVID-19 mRNA-1273 疫苗不良反应系列调查回顾。
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-12-01 DOI: 10.18926/AMO/66148
Naomi Matsumoto, Chigusa Higuchi, Chikara Miyaji, Toshiharu Mitsuhashi, Hideharu Hagiya, Soshi Takao, Takashi Yorifuji

This paper presents the results of a series of surveys conducted from July 2021 to March 2023 to investigate the post-vaccination adverse reactions to the mRNA-1273 (Moderna) vaccine among faculty, staff, and students at Okayama University. These studies complement the official surveys conducted by the Ministry of Health, Labour and Welfare (MHLW) and provide a more representative picture of adverse reactions in the general population including large numbers of healthy young people. Pain, swelling, redness at the injection site, fever, headache, and malaise were the main adverse reactions reported. The proportion of adverse reactions was generally higher after the second vaccination and decreased with each additional vaccination. No statistically significant differences in the adverse reactions were found for males and females and those with/without a history of allergy, but a lower proportion of fever was observed in older participants and those with underlying medical conditions. We also evaluated the association between adverse reactions and antibody titers after the third vaccination and found no significant differences in antibody levels one month after vaccination. This series of studies highlights the importance of conducting surveys in diverse populations to provide a more representative picture of post-vaccination adverse reactions during a pandemic.

本文介绍了 2021 年 7 月至 2023 年 3 月期间进行的一系列调查的结果,这些调查旨在调查冈山大学教职员工和学生接种 mRNA-1273(Moderna)疫苗后的不良反应。这些研究是对厚生劳动省(MHLW)开展的官方调查的补充,能够更有代表性地反映包括大量健康年轻人在内的普通人群的不良反应情况。疼痛、肿胀、注射部位发红、发热、头痛和不适是报告的主要不良反应。不良反应的比例一般在第二次接种后较高,并随着接种次数的增加而降低。男性和女性以及有/无过敏史者的不良反应在统计学上没有明显差异,但在年龄较大和有潜在疾病的参与者中,发烧的比例较低。我们还评估了不良反应与第三次接种后抗体滴度之间的关系,结果发现接种一个月后抗体水平没有显著差异。这一系列研究强调了在不同人群中开展调查的重要性,以便更有代表性地反映大流行期间接种疫苗后的不良反应。
{"title":"Review of a Series of Surveys on Adverse Reactions to the COVID-19 mRNA-1273 Vaccine at Okayama University.","authors":"Naomi Matsumoto, Chigusa Higuchi, Chikara Miyaji, Toshiharu Mitsuhashi, Hideharu Hagiya, Soshi Takao, Takashi Yorifuji","doi":"10.18926/AMO/66148","DOIUrl":"10.18926/AMO/66148","url":null,"abstract":"<p><p>This paper presents the results of a series of surveys conducted from July 2021 to March 2023 to investigate the post-vaccination adverse reactions to the mRNA-1273 (Moderna) vaccine among faculty, staff, and students at Okayama University. These studies complement the official surveys conducted by the Ministry of Health, Labour and Welfare (MHLW) and provide a more representative picture of adverse reactions in the general population including large numbers of healthy young people. Pain, swelling, redness at the injection site, fever, headache, and malaise were the main adverse reactions reported. The proportion of adverse reactions was generally higher after the second vaccination and decreased with each additional vaccination. No statistically significant differences in the adverse reactions were found for males and females and those with/without a history of allergy, but a lower proportion of fever was observed in older participants and those with underlying medical conditions. We also evaluated the association between adverse reactions and antibody titers after the third vaccination and found no significant differences in antibody levels one month after vaccination. This series of studies highlights the importance of conducting surveys in diverse populations to provide a more representative picture of post-vaccination adverse reactions during a pandemic.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"77 6","pages":"567-575"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139037332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trochanteric Claw Plate Fixation for Greater Trochanteric Fracture or Osteotomy in Total Hip Arthroplasty. 全髋关节置换术中大转子骨折或截骨的转子爪板固定术
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-12-01 DOI: 10.18926/AMO/66154
Kenichi Oe, Hirokazu Iida, Shohei Sogawa, Fumito Kobayashi, Tomohisa Nakamura, Takanori Saito

This study retrospectively evaluated 41 consecutive open reductions and internal fixations following primary or revision total hip arthroplasty, which required trochanteric claw plate fixation for greater trochanteric fracture or osteotomy between January 2008 and December 2020. The mean duration of clinical follow-up was 4.2 years (range, 1-13 years). The patients included 13 men and 28 women, with a mean age of 68 years (range, 32-87 years). The indications for intervention included trochanteric osteotomy, intraoperative fracture, and non-union including postoperative fracture in 6, 9, and 26 cases, respectively. The mean Merle d'Aubigné Clinical Score improved from 9.4 points (range, 5-15 points) pre-operatively, to 14.3 points (range, 9-18 points) at the last follow-up. Bone union occurred in 35 cases (85%), while implant breakage occurred in four cases. At the last follow-up, the mean Merle d'Aubigné Clinical Scores of bone union and non-union were 15.3 and 14.1, respectively (p=0.48). The Kaplan-Meier survival rate, with the endpoint being revision surgery for pain, non-union, dislocation, or implant breakage, at 10 years was 80.0% (95% confidence interval: 62.6-97.4%). Greater trochanteric fixation using a trochanteric claw plate yielded successful results.

本研究回顾性评估了 2008 年 1 月至 2020 年 12 月间 41 例连续的初次或翻修全髋关节置换术后开放复位和内固定术,这些患者因大转子骨折或截骨而需要转子爪钢板固定。平均临床随访时间为 4.2 年(1-13 年不等)。患者中有 13 名男性和 28 名女性,平均年龄为 68 岁(32-87 岁)。介入治疗的适应症包括转子截骨术、术中骨折和包括术后骨折在内的不愈合,分别有 6 例、9 例和 26 例。平均 Merle d'Aubigné 临床评分从术前的 9.4 分(范围为 5-15 分)提高到最后一次随访时的 14.3 分(范围为 9-18 分)。35例(85%)发生骨结合,4例发生种植体破损。最后一次随访时,骨结合和非骨结合的平均 Merle d'Aubigné 临床评分分别为 15.3 分和 14.1 分(P=0.48)。以疼痛、不愈合、脱位或植入物断裂为终点进行翻修手术的卡普兰-梅耶生存率为 80.0%(95% 置信区间:62.6%-97.4%)。使用转子爪板进行大转子固定取得了成功。
{"title":"Trochanteric Claw Plate Fixation for Greater Trochanteric Fracture or Osteotomy in Total Hip Arthroplasty.","authors":"Kenichi Oe, Hirokazu Iida, Shohei Sogawa, Fumito Kobayashi, Tomohisa Nakamura, Takanori Saito","doi":"10.18926/AMO/66154","DOIUrl":"10.18926/AMO/66154","url":null,"abstract":"<p><p>This study retrospectively evaluated 41 consecutive open reductions and internal fixations following primary or revision total hip arthroplasty, which required trochanteric claw plate fixation for greater trochanteric fracture or osteotomy between January 2008 and December 2020. The mean duration of clinical follow-up was 4.2 years (range, 1-13 years). The patients included 13 men and 28 women, with a mean age of 68 years (range, 32-87 years). The indications for intervention included trochanteric osteotomy, intraoperative fracture, and non-union including postoperative fracture in 6, 9, and 26 cases, respectively. The mean Merle d'Aubigné Clinical Score improved from 9.4 points (range, 5-15 points) pre-operatively, to 14.3 points (range, 9-18 points) at the last follow-up. Bone union occurred in 35 cases (85%), while implant breakage occurred in four cases. At the last follow-up, the mean Merle d'Aubigné Clinical Scores of bone union and non-union were 15.3 and 14.1, respectively (p=0.48). The Kaplan-Meier survival rate, with the endpoint being revision surgery for pain, non-union, dislocation, or implant breakage, at 10 years was 80.0% (95% confidence interval: 62.6-97.4%). Greater trochanteric fixation using a trochanteric claw plate yielded successful results.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"77 6","pages":"619-625"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139037334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between Cases of Total Hip Arthroplasty Followed by Colonna Capsular Arthroplasty and Lorenz Cast Reduction in Patients with Developmental Dysplasia of the Hip. 髋关节发育不良患者接受全髋关节置换术后再接受科隆纳囊关节置换术与洛伦兹石膏固定术的病例比较。
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-12-01 DOI: 10.18926/AMO/66159
Hirosuke Endo, Kazuki Yamada, Tomonori Tetsunaga, Yoshifumi Namba, Yoshihisa Sugimoto, Shigeru Mitani, Eiji Nakata, Toshifumi Ozaki

Most patients with developmental dysplasia of the hip (DDH) now receive closed-reduction treatment within 6 months after birth. The long-term outcomes of patients with late-detection DDH have remained unclear. We reviewed the clinical records of 18 patients who underwent Colonna capsular arthroplasty (n=8) or closed reduction (n=10) for developmental dysplasia of the hip as infants or young children and underwent total hip arthroplasty approximately in midlife. Both the Colonna capsular arthroplasty and closed reduction groups achieved good clinical results after total hip arthroplasty. However, the operating time was longer and the improvements of hip range of motion and clinical score were significantly worse in the Colonna capsular arthroplasty group than in the closed reduction group.

目前,大多数发育性髋关节发育不良(DDH)患者都在出生后 6 个月内接受闭合复位治疗。晚期发现的DDH患者的长期疗效仍不明确。我们回顾了18名患者的临床记录,这些患者在婴儿或幼儿时期因髋关节发育不良接受了科隆纳关节囊成形术(8人)或闭合复位术(10人),大约在中年时接受了全髋关节成形术。在全髋关节置换术后,科隆纳关节囊置换术组和闭合复位组均取得了良好的临床效果。然而,科隆纳囊性关节置换术组的手术时间更长,髋关节活动范围和临床评分的改善程度明显低于闭合复位组。
{"title":"Comparison between Cases of Total Hip Arthroplasty Followed by Colonna Capsular Arthroplasty and Lorenz Cast Reduction in Patients with Developmental Dysplasia of the Hip.","authors":"Hirosuke Endo, Kazuki Yamada, Tomonori Tetsunaga, Yoshifumi Namba, Yoshihisa Sugimoto, Shigeru Mitani, Eiji Nakata, Toshifumi Ozaki","doi":"10.18926/AMO/66159","DOIUrl":"10.18926/AMO/66159","url":null,"abstract":"<p><p>Most patients with developmental dysplasia of the hip (DDH) now receive closed-reduction treatment within 6 months after birth. The long-term outcomes of patients with late-detection DDH have remained unclear. We reviewed the clinical records of 18 patients who underwent Colonna capsular arthroplasty (n=8) or closed reduction (n=10) for developmental dysplasia of the hip as infants or young children and underwent total hip arthroplasty approximately in midlife. Both the Colonna capsular arthroplasty and closed reduction groups achieved good clinical results after total hip arthroplasty. However, the operating time was longer and the improvements of hip range of motion and clinical score were significantly worse in the Colonna capsular arthroplasty group than in the closed reduction group.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"77 6","pages":"655-663"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139037324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Nutritional Support Combined with Neuromuscular Electrical Stimulation on Muscle Strength and Thickness: A Randomized Controlled Trial in Healthy Young Adult Males. 营养支持结合神经肌肉电刺激对肌肉力量和厚度的影响:健康年轻男性的随机对照试验》。
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-12-01 DOI: 10.18926/AMO/66156
Tomohiro Ikeda, Kazunori Okamura, Masaki Hasegawa, Satoshi Tanaka, Shusaku Kanai

In the management of post-injury patients with activity limitations, methods to prevent musculoskeletal disorders and hasten recovery are important. This randomized controlled, single-blinded study was a preliminary investigation of the combined effect of nutritional support with neuromuscular electrical stimulation (NMES) on muscle strength and thickness. Healthy young adult males (median age, 21 years) were enrolled; each of their hands was randomly assigned to one of the following four groups: Placebo, Nutrition, NMES, and Nutrition + NMES. All participants received whey protein or placebo (3x/week for 6 weeks) and NMES training (3x/week for 6 weeks) on the abductor digiti minimi (ADM) muscle of either the left or right hand. ADM muscle strength and thickness were analyzed at baseline and at week 7. We analyzed 38 hands (9 Placebo, 10 Nutrition, 9 NMES, 10 Nutrition + NMES). There was significantly greater muscle strengthening in the Nutrition + NMES group compared to the Placebo group or the NMES group, but no significant difference in gain of muscle thickness. The combined intervention may be effective in improving muscle strength. Future clinical trials targeting various muscles after sports-related injuries are warranted.

在治疗受伤后活动受限的患者时,预防肌肉骨骼疾病和加快康复的方法非常重要。这项随机对照、单盲研究是对营养支持与神经肌肉电刺激(NMES)对肌肉力量和厚度的综合影响进行的初步调查。健康的年轻成年男性(中位年龄 21 岁)参加了这项研究;他们的每只手被随机分配到以下四个组中的一组:安慰剂组、营养组、NMES 组和营养 + NMES 组。所有参与者均接受乳清蛋白或安慰剂训练(每周 3 次,共 6 周)以及 NMES 训练(每周 3 次,共 6 周),训练部位为左手或右手的小腿内收肌(ADM)。在基线和第 7 周时对小臂外展肌的肌力和厚度进行分析。我们分析了 38 只手(9 只安慰剂手、10 只营养手、9 只 NMES 手、10 只营养 + NMES 手)。与安慰剂组或 NMES 组相比,营养 + NMES 组的肌肉力量明显增强,但肌肉厚度的增加没有明显差异。综合干预可能会有效改善肌肉力量。未来有必要针对运动相关损伤后的各种肌肉进行临床试验。
{"title":"Effects of Nutritional Support Combined with Neuromuscular Electrical Stimulation on Muscle Strength and Thickness: A Randomized Controlled Trial in Healthy Young Adult Males.","authors":"Tomohiro Ikeda, Kazunori Okamura, Masaki Hasegawa, Satoshi Tanaka, Shusaku Kanai","doi":"10.18926/AMO/66156","DOIUrl":"10.18926/AMO/66156","url":null,"abstract":"<p><p>In the management of post-injury patients with activity limitations, methods to prevent musculoskeletal disorders and hasten recovery are important. This randomized controlled, single-blinded study was a preliminary investigation of the combined effect of nutritional support with neuromuscular electrical stimulation (NMES) on muscle strength and thickness. Healthy young adult males (median age, 21 years) were enrolled; each of their hands was randomly assigned to one of the following four groups: Placebo, Nutrition, NMES, and Nutrition + NMES. All participants received whey protein or placebo (3x/week for 6 weeks) and NMES training (3x/week for 6 weeks) on the abductor digiti minimi (ADM) muscle of either the left or right hand. ADM muscle strength and thickness were analyzed at baseline and at week 7. We analyzed 38 hands (9 Placebo, 10 Nutrition, 9 NMES, 10 Nutrition + NMES). There was significantly greater muscle strengthening in the Nutrition + NMES group compared to the Placebo group or the NMES group, but no significant difference in gain of muscle thickness. The combined intervention may be effective in improving muscle strength. Future clinical trials targeting various muscles after sports-related injuries are warranted.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"77 6","pages":"635-645"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139037327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omental Abscess after Laparoscopic Proximal Gastrectomy Successfully Treated with Percutaneous Drainage. 腹腔镜近端胃切除术后网膜脓肿经皮引流成功治愈
IF 0.5 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-12-01 DOI: 10.18926/AMO/66160
Atsunobu Sakurai, Mayu Uka, Toshihiro Iguchi, Koji Tomita, Yusuke Matsui, Yoshihiko Kakiuchi, Shinji Kuroda, Toshiyoshi Fujiwara, Takao Hiraki

We report the case details of a 65-year-old Japanese man with an omental abscess that was discovered 43 days after he underwent a laparoscopic proximal gastrectomy for gastric cancer. His chief complaint was mild abdominal pain that had persisted for several days. The abscess was diagnosed as a rare postoperative complication. We hesitated to perform a reoperation given the invasiveness of general anesthesia and surgery, plus the possibility of postoperative adhesions and because the patient's general condition was stable and he had only mild abdominal pain. Percutaneous drainage using a 10.2-F catheter was performed with the patient under conscious sedation and computed tomography-fluoroscopy guidance, with no complications. After the procedure, the size of the abscess cavity was remarkably reduced, and 23 days later the catheter was withdrawn.

我们报告了一名 65 岁日本男子的详细病例,他在接受腹腔镜胃癌近端切除术 43 天后发现网膜脓肿。他的主诉是持续数天的轻微腹痛。脓肿被诊断为罕见的术后并发症。考虑到全身麻醉和手术的侵入性,以及术后粘连的可能性,我们犹豫是否要再次手术,因为患者的全身情况稳定,只有轻微腹痛。在有意识镇静和计算机断层扫描-荧光透视引导下,患者使用 10.2-F 导管进行了经皮引流,没有出现并发症。术后,脓腔明显缩小,23 天后拔出导管。
{"title":"Omental Abscess after Laparoscopic Proximal Gastrectomy Successfully Treated with Percutaneous Drainage.","authors":"Atsunobu Sakurai, Mayu Uka, Toshihiro Iguchi, Koji Tomita, Yusuke Matsui, Yoshihiko Kakiuchi, Shinji Kuroda, Toshiyoshi Fujiwara, Takao Hiraki","doi":"10.18926/AMO/66160","DOIUrl":"10.18926/AMO/66160","url":null,"abstract":"<p><p>We report the case details of a 65-year-old Japanese man with an omental abscess that was discovered 43 days after he underwent a laparoscopic proximal gastrectomy for gastric cancer. His chief complaint was mild abdominal pain that had persisted for several days. The abscess was diagnosed as a rare postoperative complication. We hesitated to perform a reoperation given the invasiveness of general anesthesia and surgery, plus the possibility of postoperative adhesions and because the patient's general condition was stable and he had only mild abdominal pain. Percutaneous drainage using a 10.2-F catheter was performed with the patient under conscious sedation and computed tomography-fluoroscopy guidance, with no complications. After the procedure, the size of the abscess cavity was remarkably reduced, and 23 days later the catheter was withdrawn.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"77 6","pages":"665-669"},"PeriodicalIF":0.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139037330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica Okayama
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1